Detalhe da pesquisa
1.
α-FAtE: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma.
Int J Cancer
; 154(6): 1043-1056, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37994647
2.
Development and validation of a scoring system to predict response to obeticholic acid in primary biliary cholangitis.
Clin Gastroenterol Hepatol
; 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38782175
3.
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab.
Liver Int
; 44(5): 1108-1125, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38517286
4.
Correlation between neuroimaging, neurological phenotype, and functional outcomes in Wilson's disease.
Neurol Sci
; 2024 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38291197
5.
Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET).
Gut
; 72(8): 1581-1591, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36788015
6.
Role of the Prognostic Nutritional Index in Predicting Survival in Advanced Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab.
Oncology
; 101(5): 283-291, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36657420
7.
Power Performance Verification of a Wind Farm Using the Friedman's Test.
Sensors (Basel)
; 16(6)2016 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27271628
8.
Safety and Efficacy of Lenvatinib in Very Old Patients with Unresectable Hepatocellular Carcinoma.
Target Oncol
; 19(1): 29-39, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38252195
9.
Adverse Events as Potential Predictive Factors of Activity in Patients with Advanced HCC Treated with Atezolizumab Plus Bevacizumab.
Target Oncol
; 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38689194
10.
Identification of Atezolizumab Plus Bevacizumab Prognostic Index via Recursive Partitioning Analysis in HCC: The ABE Index.
Anticancer Res
; 43(4): 1599-1610, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36974779
11.
Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population.
Eur J Cancer
; 180: 9-20, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36527976
12.
Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study.
J Cancer Res Clin Oncol
; 149(9): 5591-5602, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36509984
13.
Survival outcomes from atezolizumab plus bevacizumab versus Lenvatinib in Child Pugh B unresectable hepatocellular carcinoma patients.
J Cancer Res Clin Oncol
; 149(10): 7565-7577, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36976353
14.
Real-World Data for Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma: How Does Adherence to the IMbrave150 Trial Inclusion Criteria Impact Prognosis?
Target Oncol
; 18(2): 221-233, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36920648
15.
Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients.
Eur J Cancer
; 189: 112933, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37385069
16.
Noninvasive fibrosis tools in NAFLD: validation of APRI, BARD, FIB-4, NAFLD fibrosis score, and Hepamet fibrosis score in a Portuguese population.
Postgrad Med
; 134(4): 435-440, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35332833
17.
Effectiveness and safety of obeticholic acid in a Southern European multicentre cohort of patients with primary biliary cholangitis and suboptimal response to ursodeoxycholic acid.
Aliment Pharmacol Ther
; 53(4): 519-530, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33314220
18.
Predictors for incomplete response to ursodeoxycholic acid in primary biliary cholangitis. Data from a national registry of liver disease.
United European Gastroenterol J
; 9(6): 699-706, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34102008
19.
The Relation of CUN-BAE Index with Body Mass Index and Waist Circumference in Adults Aged 50 to 85 Years: The MCC-Spain Study.
Nutrients
; 12(4)2020 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32260185
20.
Bacterial Infections in Patients with Liver Cirrhosis in an Internal Medicine Department.
GE Port J Gastroenterol
; 26(5): 324-332, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31559323